Bank Julius Baer & Co
TNDM icon

Bank Julius Baer & Co’s Tandem Diabetes Care TNDM Stock Holding History

Bank Julius Baer & Co’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,997
Closed -$609K – 604
2023
Q1 		$609K Buy
14,997
+1,094
+8% +$45.3K ﹤0.01% 326
2022
Q4 		$625K Buy
13,903
+814
+6% +$36.9K ﹤0.01% 319
2022
Q3 		$626K Sell
13,089
-16,095
-55% -$882K ﹤0.01% 313
2022
Q2 		$1.73M Sell
29,184
-9,224
-24% -$757K 0.01% 223
2022
Q1 		$4.47M Sell
38,408
-5,750
-13% -$671K 0.03% 178
2021
Q4 		$6.65M Buy
44,158
+39,758
+904% +$5.37M 0.04% 180
2021
Q3 		$525K Sell
4,400
-5
-0.1% -$551 ﹤0.01% 423
2021
Q2 		$429K Buy
4,405
+5
+0.1% +$446 ﹤0.01% 473
2021
Q1 		$388K Hold
4,400
– – ﹤0.01% 485
2020
Q4 		$421K Hold
4,400
– – ﹤0.01% 480
2020
Q3 		$499K Hold
4,400
– – ﹤0.01% 386
2020
Q2 		$435K Sell
4,400
-6,676
-60% -$533K 0.01% 378
2020
Q1 		$712K Buy
+11,076
New +$776K 0.02% 271

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Bank Julius Baer & Co's TNDM Position: Q2 2023 in Review

Bank Julius Baer & Co sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 14,997 shares — an estimated $609K sold.

Bank Julius Baer & Co first reported a position in TNDM in Q1 2020 and held it in 13 quarters. The position peaked at $6.65M in Q4 2021. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

  • Bank Julius Baer & Co reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
  • Bank Julius Baer & Co sold 14,997 Tandem Diabetes Care shares in Q2 2023, an estimated $609K.
  • Bank Julius Baer & Co first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 13 quarters.
  • Bank Julius Baer & Co's Tandem Diabetes Care position peaked at $6.65M in Q4 2021.
  • 247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Bank Julius Baer & Co's 13F filing for Q2 2023, filed 20 Jul 2023.